Founded in January 1994, Yunnan Panlong Yunhai Pharmaceutical Corporation is an internationalized pharmaceutical enterprise group integrating drug research, development, production and sales.
Since established, Panlong Yunhai has made full use of the advantage of Yunnan in abundant and pure medicinal material resources to develop PAIDUYANGYAN JIAONANG (Capsules) and LINGDANCAO KELI (Granules) closely centered on the development strategy of health in a broad sense.
Researched and produced under the theory of “eliminating toxicant for health preservation by regulation and tonifying qi”, PAIDUYANGYAN JIAONANG (Capsules) may benefit qi for activating blood circulation, purge, detoxify, regulate internal secretion, promote the body to restore balance, thus to improve acne and stain arising from constipation due to toxicant in the body and occurrence of toxicant on skin.
Panlong Yunhai has been devoted to the industry of Panax notoginseng. It controls the purity and quality of Panax notoginseng from the source. Relying on the characteristics of “safety (low pesticides residual and heavy metals content) and high efficiency (high content of Saponins)”, it has continuously established new benchmark for the Panax notoginseng industry.
Lingdancao Keli (Granules) is a Chinese patent medicine produced with modern pharmaceutical technology and quality standard, with significant effect on prevention and treatment of throat diseases and coughing with lung heat. The quality standard of Lingdancao Keli (Granules) has been recorded in Pharmacopoeia of the People’s Republic of China.
